ASP Isotopes Inc
NASDAQ:ASPI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (11), the stock would be worth $-4.62 (182% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -13.4 | $5.61 |
0%
|
| Industry Average | 11 | $-4.62 |
-182%
|
| Country Average | 14.4 | $-6.02 |
-207%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| US |
A
|
ASP Isotopes Inc
NASDAQ:ASPI
|
706.3m USD | -13.4 | -4 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
83B USD | 20.9 | 32.3 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
12.4T JPY | 12.6 | 25.7 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
75.8B USD | 21.3 | 36.5 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 5.8 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
274.5B CNY | 21.3 | 24.9 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
26B CHF | 17 | 24.2 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.5T INR | 38 | 63.1 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 28.9 | 54.8 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
25B USD | 10.9 | 15.8 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 10.3 | 17.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10 |
| Median | 14.4 |
| 70th Percentile | 21.5 |
| Max | 1 767 274.1 |
Other Multiples
ASP Isotopes Inc
Glance View
ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. The company is headquartered in Boca Raton, Florida and currently employs 4 full-time employees. The company went IPO on 2022-11-10. The firm has developed the aerodynamic separation process (ASP technology) for the production, distribution, marketing, and sale of all isotopes. Its technology allows it to enrich elements with both low and high atomic masses. The Company’s focus is on the production and commercialization of enriched Molybdenum-100 (Mo-100). The company also intends to use the ASP technology licensed to produce enriched Uranium-235 (U-235). The company operates principally through subsidiaries: ASP Isotopes Guernsey Limited, which is focused on the development and commercialization of high value, low volume isotopes for specialized end markets (such as Mo-100 and others, including Silicon-28); Enriched Energy LLC, which is focused on the development and commercialization of uranium for the nuclear energy market; and ASP Isotopes UK Ltd, which is the licensee of the ASP technology under the exclusive license agreement with Klydon Proprietary Ltd.
